ID: ALA2235126

Max Phase: Preclinical

Molecular Formula: C9H12N2

Molecular Weight: 148.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(C/C=N/N)cc1

Standard InChI:  InChI=1S/C9H12N2/c1-8-2-4-9(5-3-8)6-7-11-10/h2-5,7H,6,10H2,1H3/b11-7+

Standard InChI Key:  OQNICHJRWSLLON-YRNVUSSQSA-N

Associated Targets(Human)

Gamma-amino-N-butyrate transaminase 140 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 148.21Molecular Weight (Monoisotopic): 148.1000AlogP: 1.48#Rotatable Bonds: 2
Polar Surface Area: 38.38Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.65CX LogP: 1.68CX LogD: 1.68
Aromatic Rings: 1Heavy Atoms: 11QED Weighted: 0.38Np Likeness Score: -0.26

References

1. Bansal SK, Sinha BN, Khosa RL, Olson AJ.  (2011)  Novel GABA-AT inhibitors: QSAR and docking based virtual screening of phenyl substituted -phenyl ethylidene hydrazine analogues,  20  (9): [10.1007/s00044-010-9390-6]

Source